NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement

Detalles Bibliográficos
Autores principales: Piepiorka-Broniecka, Marta, Michalski, Tomasz A., Figatowski, Tomasz, Wojtowicz, Andrzej, Jurowiecki, Jarosław, Stanska, Aleksandra, Rogowski, Jan, Jaguszewski, Milosz J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007476/
https://www.ncbi.nlm.nih.gov/pubmed/34897639
http://dx.doi.org/10.5603/CJ.a2021.0158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007476/
https://www.ncbi.nlm.nih.gov/pubmed/34897639
http://dx.doi.org/10.5603/CJ.a2021.0158

Ejemplares similares